Carbinoxamine Maleate
NDC 73684-110, CARBINOXAMINE MALEATE, tablet, from BluCrest Pharmaceuticals, LLC.
- Product NDC
- 73684-110
- Status
- Listed
- Labeler
- BluCrest Pharmaceuticals, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207484
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/73684-110 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CARBINOXAMINE MALEATE6 mg/1
Pharmacologic classes
Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 73684-110-60 | 73684011060 | 60 TABLET in 1 BOTTLE (73684-110-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/163db29b-f035-6696-e063-6294a90a7e06
Use it
Look up 73684-110 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/73684-110 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 73684-110. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.